Alzheimer's disease biomarkers: correspondence between human studies and animal models

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI

Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · see citing works

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700 · see citing works

Alzheimer’s Disease Neuroimaging Initiative

Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Toga, A. W., & Beckett, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,493 · see citing works

N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology

MOFFETT, J., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,413 · see citing works

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246 · see citing works

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128 · see citing works

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Clark, C. M. (2011) · JAMA · doi:10.1001/jama.2010.2008 · Cited by 1,117 · see citing works

Imaging β-amyloid burden in aging and dementia

Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104 · see citing works

In-vivo measurement of activated microglia in dementia

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · see citing works

Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease

Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 2× · see citing works

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · see citing works

Selective changes of resting-state networks in individuals at risk for Alzheimer’s disease

Sorg, C., Riedl, V., Mühlau, M., Calhoun, V. D., Eichele, T., Läer, L., Drzezga, A., Förstl, H., Kurz, A., Zimmer, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708803104 · Cited by 1,036 · see citing works

Classification and basic pathology of Alzheimer disease

Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031 · see citing works

2012 Alzheimer's disease facts and figures Alzheimer's Association ∗

Thies, W. H., & Bleiler, L. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 984 · see citing works

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937 · see citing works

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD

Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910 · see citing works

Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults

Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897 · see citing works

Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI

Wang, L. Y., Zang, Y., Yong He, A., Liang, M., Zhang, X., Tian, L., Wu, T., Jiang, T., & Li, K. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.12.033 · Cited by 845 · see citing works

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease

Georganopoulou, D. G., Chang, L., Nam, J.-M., Thaxton, C. S., Mufson, E. J., Klein, W. L., & Mirkin, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409336102 · Cited by 835 · see citing works

-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · see citing works

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · see citing works

Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer Disease

Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774 · see citing works

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

Landau, S. M., Harvey, D., Madison, C. M., Koeppe, R. A., Reiman, E. M., Foster, N. L., Weiner, M. W., & Jagust, W. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.002 · Cited by 750 · see citing works

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study

Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005) · Human Brain Mapping · doi:10.1002/hbm.20160 · Cited by 734 · see citing works

Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis

Celone, K., Calhoun, V. D., Dickerson, B. C., Atri, A., Chua, E. F., Miller, S. L., DePeau, K. M., Rentz, D., Selkoe, D. J., Blacker, D., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2250-06.2006 · Cited by 733 · see citing works

PET of Brain Amyloid and Tau in Mild Cognitive Impairment

Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., Lavretsky, H., Burggren, A. C., Cole, G. M., Vinters, H. V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054625 · Cited by 731 · see citing works

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand ¹⁸ F-AV-45 (Flobetapir F 18)

Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., Dannals, R. F., Nandi, A., Brašić, J. R., Ye, W., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069088 · Cited by 684 · cited 4× · see citing works

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Rowe, C. C., Ackerman, U., Browne, W. F., Mulligan, R. S., Pike, K. E., O'Keefe, G. J., Tochon‐Danguy, H., Chan, G., Berlangieri, S. U., Jones, G. R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70001-2 · Cited by 671 · see citing works

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

Buchhave, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.155 · Cited by 664 · see citing works

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

Killiany, R., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Sándor, T., Jolesz, F. A., Tanzi, R. E., Jones, K. J., Hyman, B. T., & Albert, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 659 · see citing works

Decreased β-Amyloid_1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656 · see citing works

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Hampel, H. J., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 630 · see citing works

Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Bateman, R. J., Munsell, L. Y., Morris, J. C., Swarm, R., Yarasheski, K. E., & Holtzman, D. M. (2006) · Nature Medicine · doi:10.1038/nm1438 · Cited by 599 · see citing works

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Barthel, H., Gertz, H., Dresel, S. H. J., Peters, O., Bartenstein, P., Büerger, K., Hiemeyer, F. J., Wittemer‐Rump, S., Seibyl, J. P., Reininger, C. B., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70077-1 · Cited by 588 · see citing works

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582 · see citing works

Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience

Johnson, N. A., Jahng, G., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno‐Tempini, M. L., & Schuff, N. W. (2005) · Radiology · doi:10.1148/radiol.2343040197 · Cited by 580 · see citing works

White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging

Bozzali, M. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.742 · Cited by 568 · see citing works

Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study

Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000244749.20056.d4 · Cited by 518 · see citing works

Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment

Koenig, T. W., Prichep, L. S., Dierks, T., Hubl, D., Wahlund, L., John, E. R., & Jelić, V. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.008 · Cited by 514 · see citing works

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · see citing works

Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease

Zhang, Y., Schuff, N. W., Jahng, G., Bayne, W., Mori, S., Schad, L. R., Mueller, S. G., Du, A., Kramer, J. H., Yaffe, K. S., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000250326.77323.01 · Cited by 508 · see citing works

Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease

Grady, C. L., McIntosh, A. R., Beig, S., Keightley, M., Burian, H., & Black, S. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00986.2003 · Cited by 504 · see citing works

Intrathecal inflammation precedes development of Alzheimer's disease

Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · see citing works

White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study

Medina, D., deToledo-Morrell, L., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.026 · Cited by 492 · see citing works

Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 490 · see citing works

Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

Blennow, K. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.213 · Cited by 487 · see citing works

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease

Jelić, V., Johansson, S.-E., Almkvist, O., Shigeta, M., Julin, P., Nordberg, A. K., Winblad, B. G., & Wahlund, L. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00153-6 · Cited by 471 · see citing works

Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging

Rose, S. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.528 · Cited by 465 · see citing works

Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study

Huang, C. C., Wahlund, L., Dierks, T., Julin, P., Winblad, B. G., & Jelić, V. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00454-5 · Cited by 464 · see citing works

Proteome-based plasma biomarkers for Alzheimer's disease

Hye, A., Lynham, S., Thambisetty, M., Čaušević, M., Campbell, J., Byers, H. L., Hooper, C., Rijsdijk, F. V., Tabrizi, S. J., Banner, S. J., et al. (2006) · Brain · doi:10.1093/brain/awl279 · Cited by 463 · see citing works

Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease

Kantarci, K., Jack, C. R., Xu, Y., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2000) · Neurology · doi:10.1212/wnl.55.2.210 · Cited by 460 · see citing works

Relationships between biomarkers in aging and dementia

Jagust, W. J., Landau, S. M., Shaw, L. M., Trojanowski, J. Q., Koeppe, R. A., Reiman, E. M., Foster, N. L., Petersen, R. C., Weiner, M. W., Price, J. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc010c · Cited by 456 · see citing works

fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease

Sperling, R. A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.44 · Cited by 455 · see citing works

Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk

Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434 · see citing works

Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain

Choi, S., Golding, G., Zhuang, Z., Zhang, W., Lim, N. C., Hefti, F. F., Benedum, T. E., Kilbourn, M. R., Skovronsky, D., & Kung, H. F. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065284 · Cited by 431 · see citing works

β-Amyloid burden in healthy aging: Regional distribution and cognitive consequences

Rodrigue, K. M., Kennedy, K. M., Devous, M. D., Rieck, J. R., Hebrank, A. C., Diaz-Arrastia, R., Mathews, D., & Park, D. C. (2012) · Neurology · doi:10.1212/wnl.0b013e318245d295 · Cited by 419 · see citing works

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Pratico, D., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & Fitzgerald, G. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1777 · Cited by 405 · see citing works

Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory

de Haan, W., Pijnenburg, Y. A. L., STRIJERS, R. L. M., van der Made, Y., van der Flier, W. M., Scheltens, P., & Stam, C. J. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-101 · Cited by 404 · see citing works

Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

Licastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V. M., & Grimaldi, L. M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00226-x · Cited by 400 · see citing works

Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging

Dai, W., López, O. L., Carmichael, O. T., Becker, J. T., Kuller, L. H., & Gach, H. M. (2009) · Radiology · doi:10.1148/radiol.2503080751 · Cited by 393 · see citing works

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

Abdi, F. A., Quinn, J. F., Jankovic, J. J., McIntosh, M. W., Leverenz, J. B., Peskind, E. R., Nixon, R., Nutt, J. G., Chung, K., Zabetian, C. P., et al. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9309 · Cited by 385 · see citing works

Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain

Klunk, W. E., Lopresti, B. J., Ikonomović, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G.-F., Shao, L., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2990-05.2005 · Cited by 376 · see citing works

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease

Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G. L., Burkhard, P. R., Hochstrasser, D. F., & Sanchez, J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300470 · Cited by 375 · see citing works

Amyloid Imaging with18F-Florbetaben in Alzheimer Disease and Other Dementias

Villemagne, V. L., Ong, K. T., Mulligan, R. S., Holl, G., Pejoska, S., Jones, G. R., O'Keefe, G. J., Ackerman, U., Tochon‐Danguy, H., Chan, J. G., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089730 · Cited by 374 · see citing works

Microglial activation and amyloid deposition in mild cognitive impairment: A PET study

Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367 · see citing works

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

Fleisher, A. S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.150 · Cited by 364 · see citing works

Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients

Machulda, M. M., Ward, H. A., Borowski, B., Gunter, J. L., H., R., O’Brien, P. C., Petersen, R. C., Boeve, B. F., Knopman, D. S., Tang‐Wai, D. F., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000079052.01016.78 · Cited by 351 · see citing works

MCI conversion to dementia and the APOE genotype

Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff‐Detto, V., Salmon, É., Baron, J., Cristofaro, M. T. D., Padovani, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147469.18313.3b · Cited by 344 · see citing works

19F and 1H MRI detection of amyloid β plaques in vivo

Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C. (2005) · Nature Neuroscience · doi:10.1038/nn1422 · Cited by 339 · see citing works

Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies

O'Brien, J. T., Colloby, S. J., Fenwick, J., Williams, E. D., Firbank, M., Burn, D. J., Aarsland, D., & McKeith, I. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.919 · Cited by 334 · see citing works

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

Fodero‐Tavoletti, M. T., Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G. J., et al. (2011) · Brain · doi:10.1093/brain/awr038 · Cited by 329 · see citing works

A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous system

Bateman, R. J., Siemers, E. R., Mawuenyega, K. G., Wen, G., Browning, K. R., Sigurdson, W. C., Yarasheski, K. E., Friedrich, S. W., DeMattos, R. B., May, P. C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21623 · Cited by 322 · see citing works

Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

Lewczuk, P., Esselmann, H., Otto, M., Maler, J. M., Henkel, A. W., Henkel, M. K., Eikenberg, O., Antz, C., Krause, W., Reulbach, U., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00086-1 · Cited by 309 · see citing works

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

Puchades, M. A., Hansson, S., Nilsson, C. L., Andreasen, N., Blennow, K., & Davidsson, P. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.005 · Cited by 306 · see citing works

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

Arnáiz, E., Jelic, V., Almkvist, O., Wahlund, L.-O., Winblad, B., Valind, S., & Nordberg, A. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00045 · Cited by 302 · see citing works

Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography

Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0673-07.2007 · Cited by 300 · see citing works

Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J., & Ross, B. D. (1995) · Radiology · doi:10.1148/radiology.195.1.7892497 · Cited by 299 · see citing works

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study

Fellgiebel, A., Wille, P., Müller, M. J., Winterer, G., Scheurich, A., Vucurevic, G., Schmidt, L. G., & Stoeter, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077817 · Cited by 298 · see citing works

P1‐071: Intensity of dementia through latent variable modelling (I‐DeLV) in the AIBL cohort

Burnham, S. C., Graham, P. L., Wilson, B., Ames, D. J., Macaulay, L. S., Martins, R. N., Masters, C. L., Maruff, P. T., Rowe, C. C., Szoeke, C. E. I., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.347 · Cited by 292 · see citing works

Sensitive ELISA detection of amyloid‐β protofibrils in biological samples

Englund, H., Sehlin, D., Johansson, A., Nilsson, L. N. G., Gellerfors, P., Paulie, S., Lannfelt, L., & Pettersson, F. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04759.x · Cited by 292 · see citing works

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer’s disease mutations

Ringman, J. M., O'Neill, J., Geschwind, D., Medina, L., Apostolova, L. G., Rodriguez, Y., Schaffer, B., Varpetian, A., Tseng, B., Ortiz, F., et al. (2007) · Brain · doi:10.1093/brain/awm102 · Cited by 290 · see citing works

Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment

Hampel, H., Teipel, S. J., Fuchsberger, T., Andreasen, N., Wiltfang, J., Otto, M., Shen, Y., Dodel, R., Du, Y., Farlow, M., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001473 · Cited by 287 · see citing works

Prediction of Alzheimer’s Disease Using the CSF Aβ42/Aβ40 Ratio in Patients with Mild Cognitive Impairment

Hansson, O., Zetterberg, H., Buchhave, P., Andréasson, U., Londos, E., Minthon, L., & Blennow, K. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100926 · Cited by 286 · see citing works

Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease

Dierks, T., Jelić, V., Pascual-Marqui, R. D., Wahlund, L., Julin, P., Linden, D. E. J., Maurer, K., Winblad, B. G., & Nordberg, A. K. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00427-2 · Cited by 283 · see citing works

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Langbaum, J. B. S., Chen, K., Lee, W., Reschke, C., Bandy, D., Fleisher, A. S., Alexander, G. E., Foster, N. L., Weiner, M. W., Koeppe, R. A., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.072 · Cited by 279 · see citing works

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

Walker, Z. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.134 · Cited by 279 · see citing works

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

Hansson, O., Zetterberg, H., Vanmechelen, E., Vanderstichele, H., Andréasson, U., Londos, E., Wallin, A., Minthon, L., & Blennow, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.027 · Cited by 276 · see citing works

Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231

Büerger, K., Zinkowski, R. P., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann‐Kiefer, K., DeBernardis, J. F., Kerkman, D. J., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1267 · Cited by 275 · see citing works

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

Wadghiri, Y. Z., Sigurdsson, E. M., Sadowski, M. J., Elliott, J. I., Li, Y., Scholtzova, H., Tang, C. Y., Aguinaldo, G., Pappolla, M. A., Duff, K., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10529 · Cited by 273 · see citing works

High‐molecular‐weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., & Nakagawa, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-150359 · Cited by 264 · see citing works

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

Chen, Y., Wolk, D. A., Reddin, J. S., Korczykowski, M., Martínez‐Sánchez, P., Musiek, E. S., Newberg, A. B., Julin, P., Arnold, S. E., Greenberg, J. H., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31823a0ef7 · Cited by 259 · see citing works

Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory

Golby, A. J. (2005) · Brain · doi:10.1093/brain/awh400 · Cited by 259 · see citing works

Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging

Koffie, R. M., Farrar, C. T., Saidi, L.-J., William, C. M., Hyman, B. T., & Spires‐Jones, T. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111405108 · Cited by 259 · see citing works

Large‐scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

Itoh, N., Arai, H., Urakami, K., Ishiguro, K., Ohno, H., Hampel, H., Buerger, K., Wiltfang, J., Otto, M., Kretzschmar, H., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1054 · Cited by 256 · see citing works

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

Büerger, K., Teipel, S. J., Zinkowski, R. P., Blennow, K., Arai, H., Engel, R. R., Hofmann‐Kiefer, K., McCulloch, C., Ptok, U., Heun, R., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.627 · Cited by 255 · see citing works

Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's disease

Demattos, R. B., Bales, K. R., Parsadanian, M., O'Dell, M. A., Foss, E. M., Paul, S. M., & Holtzman, D. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00889.x · Cited by 253 · see citing works

ASL Perfusion MRI Predicts Cognitive Decline and Conversion From MCI to Dementia

Chao, L. L., Buckley, S. T., Kornak, J., Schuff, N. W., Madison, C. A., Yaffe, K. S., Miller, B. L., Kramer, J. H., & Weiner, M. W. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181b4f736 · Cited by 252 · see citing works

Increased CSF F 2 -isoprostane concentration in probable AD

Montine, T. J., Beal, M. F., Cudkowicz, M., O’Donnell, H., Margolin, R. A., McFarland, L. L., Bachrach, A., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251 · see citing works

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

Camus, V., Payoux, P., Barré, L., Desgranges, B., Voisin, T., Tauber, C., Joie, R. L., Tafani, M., Hommet, C., Chételat, G., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2021-8 · Cited by 250 · see citing works

Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment.

Stebbins, G. T., & Murphy, C. M. (2009) · Behavioural Neurology · doi:10.1155/2009/915041 · Cited by 245 · see citing works

β-Amyloid Accumulation Correlates with Cognitive Dysfunction in the Aged Canine

Cummings, B. J., Head, E., Afagh, A., Milgram, N. W., & Cotman, C. W. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0039 · Cited by 243 · see citing works

Disturbed fluctuations of resting state EEG synchronization in Alzheimer's disease

Stam, C. J., Montez, T., Jones, B. F., Rombouts, S. A. R. B., van der Made, Y., Pijnenburg, Y. A. L., & Scheltens, P. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.09.022 · Cited by 242 · see citing works

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

Craig‐Schapiro, R., Kühn, M., Xiong, C., Pickering, E. H., Liu, J., Misko, T. P., Perrin, R. J., Bales, K. R., Soares, H. D., Fagan, A. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018850 · Cited by 235 · see citing works

Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet

Lemere, C. A., Beierschmitt, A., Iglesias, M., Spooner, E. T., Bloom, J. K., Leverone, J. F., Zheng, J. B., Seabrook, T. J., Louard, D., Li, D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63296-8 · Cited by 230 · see citing works

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer’s disease

Grossman, M., Farmer, J., Leight, S., Work, M., Moore, P., Van Deerlin, V., Pratico, D., Clark, C. M., Coslett, H. B., Chatterjee, A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20477 · Cited by 228 · see citing works

Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease

Schupf, N., Tang, M. X., Fukuyama, H., Manly, J., Andrews, H., Mehta, P., Ravetch, J., & Mayeux, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805902105 · Cited by 225 · see citing works

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

Zetterberg, H., Andreasson, U., Hansson, O., Wu, G., Sankaranarayanan, S., Andersson, M. E., Buchhave, P., Londos, E., Umek, R. M., Minthon, L., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1102 · Cited by 224 · see citing works

The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET

Nestor, P. J. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.11.1521 · Cited by 217 · see citing works

Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups

Fleisher, A. S., Sherzai, A., Taylor, C., Langbaum, J. B. S., Chen, K., & Buxton, R. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.021 · Cited by 217 · see citing works

Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging

Poduslo, J. F., Wengenack, T. M., Curran, G. L., Wısnıewskı, T., Sigurdsson, E. M., Macura, S. I., Borowski, B., & Jack, C. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0550 · Cited by 216 · see citing works

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration

Cummings, J. L., Henchcliffe, C., Schaier, S., Simuni, T., Waxman, A., & Kemp, P. M. (2011) · Brain · doi:10.1093/brain/awr177 · Cited by 213 · see citing works

Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment

Riemenschneider, M. J., Lautenschlager, N. T., Wagenpfeil, S., Diehl, J., Drzezga, A. E., & Kurz, A. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1729 · Cited by 212 · see citing works

Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206 · see citing works

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease

Schuff, N. W., Amend, D. L., Ezekiel, F., Steinman, S., Tanabe, J., Norman, D. M., Jagust, W. J., Kramer, J. H., Mastrianni, J. A., Fein, G., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1513 · Cited by 203 · see citing works

Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis

Redwine, J. M., Kosofsky, B. E., Jacobs, R. E., Games, D., Reilly, J. F., Morrison, J. H., Young, W. G., & Bloom, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242746599 · Cited by 201 · see citing works

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

Davidsson, P., Brinkmalm, A., Nilsson, C. L., Lindbjer, M., Paulson, L., Andreasen, N., Gren, M., & Blennow, K. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00015 · Cited by 200 · see citing works

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

Marjańska, M., Curran, G. L., Wengenack, T. M., Henry, P., Bliss, R., Poduslo, J. F., Jack, C. R., Uǧurbil, K., & Garwood, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505513102 · Cited by 200 · see citing works

Biochemical markers in persons with preclinical familial Alzheimer disease

Ringman, J. M., Younkin, S. G., Pratico, D., Seltzer, W., Cole, G. M., Geschwind, D. H., Rodriguez-Agudelo, Y., Schaffer, B., Fein, J., Sokolow, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000303973.71803.81 · Cited by 198 · see citing works

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

Jack, C. R., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., Adriany, G., Gröhn, O. H. J., Grimm, R. C., & Poduslo, J. F. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20266 · Cited by 196 · see citing works

Longitudinal stability of CSF biomarkers in Alzheimer's disease

Blennow, K., Zetterberg, H., Minthon, L., Lannfelt, L., Strid, S., Annas, P., Basun, H., & Andreasen, N. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.064 · Cited by 193 · see citing works

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias

Colloby, S. J., McParland, S., O'Brien, J. T., & Attems, J. (2012) · Brain · doi:10.1093/brain/aws211 · Cited by 188 · see citing works

Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment

van Deursen, J. A., Vuurman, E. F. P. M., Verhey, F. R. J., van Kranen-Mastenbroek, V. H. J. M., & Riedel, W. J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0083-y · Cited by 187 · see citing works

The potential of functional MRI as a biomarker in early Alzheimer's disease

Sperling, R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.009 · Cited by 187 · see citing works

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease

Finehout, E. J., Franck, Z., Choe, L. H., Relkin, N. R., & Lee, K. H. (2006) · Annals of Neurology · doi:10.1002/ana.21038 · Cited by 185 · see citing works

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease

Zhang, J., Goodlett, D. R., Quinn, J. F., Peskind, E. R., Kaye, J. A., Zhou, Y. F., Pan, C., Yi, E. C., Eng, J. K., Wang, Q., et al. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7205 · Cited by 174 · see citing works

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients

Kohnken, R. E., Büerger, K., Zinkowski, R. P., Miller, C., Kerkman, D. J., DeBernardis, J. F., Shen, J., Möller, H., Davies, P., & Hampel, H. J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01178-2 · Cited by 173 · see citing works

Abnormal fronto‐parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study

Babiloni, C., Ferri, R., Moretti, D. V., Strambi, A., Binetti, G. G., Forno, G. D., Ferreri, F., Lanuzza, B., Bonato, C., Nobili, F. M., et al. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03333.x · Cited by 172 · see citing works

Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition

Song, S.-K., Kim, J. H., Lin, S.-J., Brendza, R. P., & Holtzman, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.003 · Cited by 170 · see citing works

Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

Blasko, I., Lederer, W., OBERBAUER, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170 · see citing works

Age and diagnostic performance of Alzheimer disease CSF biomarkers

Mattsson, N., Rosén, E., Hansson, O., Andreasen, N. C., Parnetti, L., Jonsson, M. A. G., Herukka, S., van der Flier, W. M., Blankenstein, M. A., Ewers, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182477eed · Cited by 166 · see citing works

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Chen, K., Langbaum, J. B. S., Fleisher, A., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 166 · see citing works

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice

Sanchez‐Ramos, J., Song, S., Sava, V. M., Catlow, B. J., Lin, X., Mori, T., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.071 · Cited by 164 · see citing works

Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease

Rombouts, S. A. R. B. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.665 · Cited by 162 · see citing works

MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study

Tapiola, T., Pennanen, C., Tapiola, M., Tervo, S., Kivipelto, M., Hänninen, T., Pihlajamaki, M. M., Laakso, M. P., Hallikainen, M., Hämäläinen, A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.007 · Cited by 160 · see citing works

Quinoline‐n‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

Kulkarni, P. V., Roney, C. A., Antich, P. P., Bonte, F. J., Raghu, A. V., & Aminabhavi, T. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.59 · Cited by 159 · see citing works

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile

Dedeoglu, A., Choi, J., Cormier, K., Kowall, N. W., & Jenkins, B. G. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.079 · Cited by 158 · see citing works

Amyloid β protein in plasma from patients with sporadic Alzheimer's disease

Tamaoka, A., Fukushima, T., Sawamura, N., Ishikawa, K., Oguni, E., Komatsuzaki, Y., & Shoji, S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00143-8 · Cited by 154 · see citing works

Serial MRI and CSF biomarkers in normal aging, MCI, and AD

Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Trojanowski, J. Q., Shaw, L. M., Bernstein, M. A., Aisen, P. S., Weiner, M., Petersen, R. C., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7ca82 · Cited by 154 · see citing works

Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease

Lau, J. C., Lerch, J. P., Sled, J. G., Henkelman, R. M., Evans, A. C., & Bedell, B. J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.252 · Cited by 151 · see citing works

In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease

Smith, K. D. B., Kallhoff, V., Zheng, H., & Pautler, R. G. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.046 · Cited by 150 · see citing works

<i>In Vivo</i>Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice

Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148 · see citing works

Trajectories of brain loss in aging and the development of cognitive impairment

Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000280577.43413.d9 · Cited by 144 · see citing works

Dissociation of regional activation in mild AD during visual encoding

Kato, T., Knopman, D. S., & Liu, H. (2001) · Neurology · doi:10.1212/wnl.57.5.812 · Cited by 143 · see citing works

Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1

Platt, B., Drever, B. D., Koss, D. J., Stoppelkamp, S., Jyoti, A., Plano, A., Utan, A., Merrick, G., Ryan, D., Melis, V., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027068 · Cited by 141 · see citing works

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET

Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.005 · Cited by 138 · see citing works

Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease

Vanhoutte, G., Dewachter, I., Borghgraef, P., Leuven, F. V., & der Linden, A. V. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20385 · Cited by 137 · see citing works

<i>In Vivo</i>Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders

Maeda, J., Zhang, M.-R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3076-10.2011 · Cited by 136 · see citing works

High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein–Bound Mass Signatures

Lopez, M. F., Mikulskis, A., Kuzdzal, S. A., Bennett, D. A., Kelly, J., Golenko, E. E., DiCesare, J. L., Denoyer, E. R., Patton, W. F., Ediger, R., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053090 · Cited by 136 · see citing works

Detection of amyloid plaques targeted by USPIO-Aβ1–42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

Yang, J., Zaim Wadghiri, Y., Minh Hoang, D., Tsui, W., Sun, Y., Chung, E., Li, Y., Wang, A., de Leon, M., & Wisniewski, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.023 · Cited by 135 · see citing works

Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease

Galvin, J. E., Price, J. L., Yan, Z., Morris, J. C., & Sheline, Y. I. (2011) · Neurology · doi:10.1212/wnl.0b013e31821ccc83 · Cited by 135 · see citing works

Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS

Cao, C., Arendash, G. W., Dickson, A., Mamcarz, M. B., Lin, X., & Ethell, D. W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.015 · Cited by 130 · see citing works

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot study

Lin, K., Hsu, W., Hsiao, I., Wey, S., Jin, L., Skovronsky, D., Wai, Y., Chang, H.-P., Lo, C.-W., Yao, C.-H., et al. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.02.003 · Cited by 130 · see citing works

Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue

Choi, S., Schneider, J. A., Bennett, D. A., Beach, T. G., Bedell, B. J., Zehntner, S. P., Krautkramer, M. J., Kung, H. F., Skovronsky, D., Hefti, F. F., et al. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31821300bc · Cited by 129 · see citing works

Intra-Individual Stability of CSF Biomarkers for Alzheimer's Disease over Two Years

Zetterberg, H., Pedersen, M., LIND, K., Svensson, M., Rolstad, S., Eckerström, C., Syversen, S., Mattsson, U.-B., Ysander, C., Mattsson, N., et al. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12307 · Cited by 126 · see citing works

PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease

Toyama, H., Ye, D. G., Ichise, M., Liow, J., Cai, L., Jacobowitz, D. M., Musachio, J. L., Hong, J. S., Crescenzo, M., Tipre, D. N., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1780-5 · Cited by 126 · see citing works

Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients

Rota, E., Bellone, G., Rocca, P., Bergamasco, B., Emanuelli, G., & Ferrero, P. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0562-6 · Cited by 125 · see citing works

CSF biomarkers for Alzheimer's disease: current utility and potential future use

Holtzman, D. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.003 · Cited by 122 · see citing works

Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study

Goekoop, R., Rombouts, S. A. R. B., Jonker, C., Hibbel, A., Knol, D. L., Truyen, L., Barkhof, F., & Scheltens, P. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.08.006 · Cited by 122 · see citing works

Cerebrospinal Fluid Aβ42, Tau, and F2-Isoprostane Concentrations in Patients With Alzheimer Disease, Other Dementias, and in Age-Matched Controls

Montine, T. J., Kaye, J. A., Montine, K. S., McFarland, L. L., Morrow, J. D., & Quinn, J. F. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0510-cfataf · Cited by 121 · see citing works

Biomarkers in Alzheimer's disease drug development

Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 121 · see citing works

Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging

Sun, S.-W., Song, S.-K., Harms, M. P., Lin, S.-J., Holtzman, D. M., Merchant, K. M., & Kotyk, J. J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.09.006 · Cited by 121 · see citing works

Changes in extracellular space size and geometry in APP23 transgenic mice: A model of Alzheimer's disease

Syková, E., Voříšek, I., Antonova, T., Mazel, T., Meyer-Luehmann, M., Jucker, M., Hájek, M., Or, M., & Bureš, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408235102 · Cited by 121 · see citing works

Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease

Ewers, M., Zhong, Z., Bürger, K., Wallin, A., Blennow, K., Teipel, S. J., Shen, Y., & Hampel, H. (2008) · Brain · doi:10.1093/brain/awn034 · Cited by 119 · see citing works

Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease

Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 116 · see citing works

Cerebral glucose metabolism in patients with AD and different <i>APOE</i> genotypes

Drzezga, A., Riemenschneider, M., Strassner, B., Grimmer, T., Peller, M., Knoll, A., Wagenpfeil, S., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148478.39691.d3 · Cited by 116 · see citing works

Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health

Bentley, P., Driver, J., & Dolan, R. J. (2007) · Brain · doi:10.1093/brain/awm299 · Cited by 115 · see citing works

Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease

Faure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112 · see citing works

The Cysteine Protease Inhibitor, E64d, Reduces Brain Amyloid-β and Improves Memory Deficits in Alzheimer's Disease Animal Models by Inhibiting Cathepsin B, but not BACE1, β-Secretase Activity

Hook, G., HOOK, V. Y. H., & Kindy, M. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110101 · Cited by 111 · see citing works

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Simonsen, A., Mcguire, J., Podust, V., Davies, H., Minthon, L., Skoog, I., Andreasen, N., Wallin, A., Waldemar, G., & Blennow, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.011 · Cited by 108 · see citing works

First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates

Sankaranarayanan, S., Holahan, M. A., Colussi, D. J., Crouthamel, M., Devanarayan, V., Ellis, J. D., Espeseth, A. S., Gates, A. T., Graham, S. L., Gregro, A. R., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143628 · Cited by 107 · see citing works

Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models

Nicholson, R. M., Kusne, Y., Nowak, L. A., LaFerla, F. M., Reiman, E. M., & Valla, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.084 · Cited by 107 · see citing works

Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease

Wirths, O., Erck, C., Martens, H., Harmeier, A., Geumann, C., Jawhar, S., Kumar, S., Multhaup, G., Walter, J., Ingelsson, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178707 · Cited by 103 · see citing works

Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice

Öberg, J., Spenger, C., Wang, F., Andersson, A. D. R., Westman, E., Skoglund, P., Sunnemark, D., Norinder, U., Klason, T., Wahlund, L., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.002 · Cited by 103 · see citing works

Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice

Mueggler, T., Sturchler, C., Kindler, D., Rausch, M., Staufenbiel, M., & Rudin, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07218.2002 · Cited by 103 · see citing works

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease

Shin, J., Lee, S., Kim, S., Kim, Y.-B., & Cho, S. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.022 · Cited by 101 · see citing works

Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease

Santos, A. N., Ewers, M., Minthon, L., Simm, A., Silber, R., Blennow, K., Prvulovic, D., Hansson, O., & Hampel, H. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111361 · Cited by 101 · see citing works

EEG, Activity, and Sleep Architecture in a Transgenic AβPPswe/PSEN1A246E Alzheimer's Disease Mouse

Jyoti, A., Plano, A., Riedel, G., & Platt, B. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100879 · Cited by 100 · see citing works

Visualization of β‐amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents

Lee, P., Falangola, M. F., Nixon, R. A., Duff, K., & Helpern, J. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20196 · Cited by 97 · see citing works

Novel Reference Region Model Reveals Increased Microglial and Reduced Vascular Binding of ¹¹C-(<i>R</i>)-PK11195 in Patients with Alzheimer's Disease

Tomasi, G., Edison, P., Bertoldo, A., Roncaroli, F., Singh, P., Gerhard, A., Cobelli, C., Brooks, D. J., & Turkheimer, F. E. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050583 · Cited by 97 · see citing works

Recovery of hippocampal network connectivity correlates with cognitive improvement in mild alzheimer's disease patients treated with donepezil assessed by resting‐state fMRI

Goveas, J. S., Xie, C., Ward, B. D., Wu, Z., Li, W., Franczak, M. B., Jones, J. L., Antuono, P., & Li, S. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22662 · Cited by 96 · see citing works

Increased β‐Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects

Holsinger, R. M. D., McLean, C., Collins, S. J., Masters, C. L., & Evin, G. M. (2004) · Annals of Neurology · doi:10.1002/ana.20144 · Cited by 96 · see citing works

Cerebrospinal fluid tau, Aβ1–42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia

Jia, J., Meng, R., Sun, Y., Sun, W., Ji, X., & Jia, L. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.051 · Cited by 96 · see citing works

Decrease of N -acetylaspartate in the MTL correlates with cognitive decline of AD patients

Jessen, F., Block, W., Träber, F., Keller, E., Flacke, S., Lamerichs, R. M. J. N., Schild, H. H., & Heun, R. (2001) · Neurology · doi:10.1212/wnl.57.5.930 · Cited by 94 · see citing works

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L. C., Cortini, F., Scalabrini, D., Baron, P., Vergani, C., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0737-6 · Cited by 94 · see citing works

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

Anderson, J. J., Holtz, G., Baskin, P. P., Turner, M., Rowe, B. A., Wang, B., Kounnas, M. Z., Lamb, B. T., Barten, D. M., Felsenstein, K. M., et al. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.11.015 · Cited by 92 · see citing works

Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice

Lord, A., Englund, H., Söderberg, L., Tucker, S. M., Clausen, F., Hillered, L., Gordon, M. N., Morgan, D., Lannfelt, L., Pettersson, F. E., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06836.x · Cited by 91 · see citing works

Is it possible to automatically distinguish resting EEG data of normal elderly vs. mild cognitive impairment subjects with high degree of accuracy?

Rossini, P. M., Buscema, M., Capriotti, M., Grossi, E., Rodriguez, G., Percio, C. D., & Babiloni, C. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.026 · Cited by 91 · see citing works

Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease

Kuntner, C., Kesner, A., Bauer, M., Kremslehner, R., Wanek, T., Mandler, M., Karch, R., Stanek, J., Wolf, T., Müller, M., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0198-z · Cited by 90 · see citing works

In vivo detection of amyloid β deposition using 19F magnetic resonance imaging with a 19F-containing curcumin derivative in a mouse model of Alzheimer's disease

Yanagisawa, D., Amatsubo, T., Morikawa, S., Taguchi, H., Urushitani, M., Shirai, N., Hirao, K., Shiino, A., Inubushi, T., & Tooyama, I. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.071 · Cited by 88 · see citing works

Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease

Luo, F. R., Rustay, N. R., Ebert, U., Hradil, V. P., Cole, T. B., Llano, D. A., Mudd, S. R., Zhang, Y., Fox, G. B., & Day, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.005 · Cited by 88 · see citing works

Resting State Cortical Rhythms in Mild Cognitive Impairment and Alzheimer's Disease: Electroencephalographic Evidence

Babiloni, C., Vecchio, F., Lizio, R., Ferri, R., Rodriguez, G., Marzano, N., Frisoni, G. B., & Rossini, P. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0051 · Cited by 87 · see citing works

Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers

Barten, D. M., Cadelina, G. W., Hoque, N., DeCarr, L. B., Guss, V. L., Yang, L., Sankaranarayanan, S., Wes, P. D., Flynn, M. E., Meredith, J. E., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110161 · Cited by 87 · see citing works

A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

Simonsen, A. H., McGuire, J., Podust, V. N., Hagnelius, N.-O., Nilsson, T. K., Kapaki, E., Vassilopoulos, D., & Waldemar, G. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000110576 · Cited by 83 · see citing works

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

Galimberti, D., Schoonenboom, N. S. M., Scheltens, P., Fenoglio, C., Venturelli, E., Pijnenburg, Y. A. L., Bresolin, N., & Scarpini, E. A. (2006) · Neurology · doi:10.1212/01.wnl.0000191324.08289.9d · Cited by 82 · see citing works

Longitudinal CSF isoprostane and MRI atrophy in the progression to AD

de Leon, M. J., Mosconi, L., Li, J., Santi, S. D., Yao, Y., Tsui, W.-H., Pirraglia, E., Rich, K. E., Javier, E., Bryś, M., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0610-z · Cited by 82 · see citing works

Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance

Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · see citing works

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid

Huynh, R. A., & Mohan, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00102 · Cited by 109 · see citing works

Disease modification and Neuroprotection in neurodegenerative disorders

Cummings, J. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0096-2 · Cited by 108 · see citing works

In vivo imaging of tau pathology using multi-parametric quantitative MRI

Wells, J. A., O'Callaghan, J. M., Holmes, H. E., Powell, N. M., Johnson, R. A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X., et al. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.023 · Cited by 93 · see citing works

Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues

O’Bryant, S. E., Xiao, G., Zhang, F., Edwards, M., German, D. C., Yin, X., Como, T., Reisch, J., Huebinger, R. M., Graff‐Radford, N. R., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141041 · Cited by 87 · see citing works

Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease

Oh, J.-H., Lee, H., Song, J., Park, S. I., & Kim, H. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.004 · Cited by 81 · see citing works

The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease

Čuljak, M., Perković, M. N., Uzun, S., Štrac, D. Š., Erjavec, G. N., Leko, M. B., Šimić, G., Tudor, L., Konjevod, M., Kozumplik, O., et al. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201130092427 · Cited by 51 · see citing works

Accelerating Alzheimerʼs research through ‘natural’ animal models

Braidy, N., Poljak, A., Jayasena, T., Mansour, H., Inestrosa, N. C., & Sachdev, P. S. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000137 · Cited by 47 · see citing works

The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO

Zhang, D., Fa, H., Zhou, J., Li, S., Diao, X.-W., & Yin, W. H. (2014) · Clinical Radiology · doi:10.1016/j.crad.2014.09.019 · Cited by 41 · see citing works

The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence

Emekli‐Alturfan, E., & Alturfan, A. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07925-w · Cited by 35 · see citing works

Slow and Fast Neocortical Oscillations in the Senescence-Accelerated Mouse Model SAMP8

Castano-Prat, P., Pérez‐Zabalza, M., Perez-Mendez, L., Escorihuela, R. M., & Sanchez-Vives, M. V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00141 · Cited by 25 · see citing works

Alzheimer's disease biomarkers in animal models: closing the translational gap.

Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2013) · Europe PMC (PubMed Central) · Cited by 24 · see citing works

Enhanced expressions of neurodegeneration-associated factors, UPS impairment, and excess Aβ accumulation in the hippocampus of mice with persistent cerebral toxocariasis

Chou, C.-M., Lee, Y., Liao, C., Huang, Y.-C., & Fan, C. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2578-6 · Cited by 19 · see citing works

Quantitative multimodal multiparametric imaging in Alzheimer’s disease

Zhao, Q., Chen, X., & Zhou, Y. (2016) · Brain Informatics · doi:10.1007/s40708-015-0028-9 · Cited by 16 · see citing works

Effects of sex and estrous cycle on the brain and plasma arginine metabolic profile in rats

Zhang, J., Yu, J., Zhang, H., & Liu, P. (2021) · Amino Acids · doi:10.1007/s00726-021-03040-5 · Cited by 11 · see citing works

Few-shot prediction of amyloid β accumulation from mainly unpaired data on biomarker candidates

Yada, Y., & Naoki, H. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00321-5 · Cited by 10 · see citing works

Spatial Cognition: Prenatal Alcohol Exposure and the Memory Puzzle

Wirt, R. A., McNeela, A. M., & Hyman, J. M. (2020) · Current Biology · doi:10.1016/j.cub.2020.07.020 · Cited by 7 · see citing works

The level of IL-1?, IL-10 and IL-17A in Alzheimer's disease patients: Comparative study

Journal, B. S. (2014) · Baghdad Science Journal · doi:10.21123/bsj.11.4.1486-1492 · Cited by 4 · see citing works

The level of IL-1?, IL-10 and IL-17A in Alzheimer's disease patients: Comparative study

Hamdan, A. A., Melconian, A. K., Adhia, A. H., & Alhaidary, A. F. (2014) · Baghdad Science Journal · doi:10.21123/bsj.2014.11.4.1486-1492 · Cited by 3 · see citing works

ASSESSMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE ALTERATIONS IN THE BRAIN IN A MOUSE MODEL OF VISCERAL LARVA MIGRANS

Elgendy, D. I., Othman, A. A., Saied, E. M., & Zoghroban, H. S. (2020) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2020.130833 · Cited by 2 · see citing works

3D Mapping Reveals Network-specific Amyloid Progression and Subcortical SusceptibilityPreprint

Canter, R. G., Choi, H., Wang, J., Watson, L. A., Yao, C., Abdurrob, F., Bousleiman, S. M., Delalle, I., Chung, K., & Tsai, L.-H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/116244 · Cited by 2 · see citing works

Role of TTR in A β peptide brain efflux - Impact in Alzheimer's disease

Gaiteiro, C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/akv8-d088

Development of magnetic resonance imaging techniques for mouse models of Alzheimer's Disease

O’Callaghan, J. M. (2015) · UCL Discovery (University College London)

BIOMARKERY PŁYNU MÓZGOWO-RDZENIOWEGO W CHOROBIE ALZHEIMERA

Gartych, M., & Bukowska, D. (2019) · Kosmos · doi:10.36921/kos.2018_2413

Cortical Activity and Rhythmic Patterns in Mouse Models of Aging and Alzheimer’s Disease

Ruiz-Mejías, M., Castano-Prat, P., Donegan, T., & Sanchez-Vives, M. V. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2001105

Prediction of amyloid β accumulation from multiple biomarkers using a hierarchical Bayesian modelPreprint

Yada, Y., & Naoki, H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.21.513271

Toward a shared infrastructure for preclinical discovery: Why animal model tissue and biofluid biobanks are needed

Buttini, M., Czubala, M. A., Rozman, J., & Heneka, M. T. (2026) · Neuron · doi:10.1016/j.neuron.2026.08.005

Alzheimer's disease biomarkers in animal models: closing the translational gap.

Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2013) · Europe PMC (PubMed Central) · Cited by 24 · see citing works

Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients

Bjorkli, C., Sandvig, A., & Sandvig, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00272 · Cited by 41 · see citing works

Review Article Alzheimer's disease biomarkers in animal models: closing the translational gap

Sabbagh, J. J., Kinney, J. W., Cummings, J. L., & Ruvo, L. (2013)

Utility of Animal Models to Understand Human Alzheimer’s Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals

Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 23 · see citing works

Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine

Flood, D. G., Marek, G. J., & Williams, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.021 · Cited by 45 · see citing works